浙江拱东医疗器械股份有限公司 2025年第三季度报告

Core Points - The company guarantees the authenticity, accuracy, and completeness of the quarterly report, and assumes legal responsibility for any false records or misleading statements [2][3][8] Financial Data - The third quarter financial report for 2025 was approved by the company's board of directors and audit committee, with no objections or abstentions [3] - The financial statements are unaudited, and the report period refers to the three months from the beginning to the end of the quarter [4][7] Non-Recurring Gains and Losses - The company has identified non-recurring gains and losses, but specific amounts and reasons for classification are not detailed in the provided documents [5] Shareholder Information - Information regarding the total number of common shareholders and the top ten shareholders is mentioned, but specific details are not provided in the documents [6]